Four abstracts accepted for presentation provide updates on ongoing clinical studies and describe approaches to boost potency and preserve selectivity of Tmod™-based precision cell therapies AGOURA ...
BARCELONA, Spain--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced the ...
A2 Biotherapeutics Presents Data from Ongoing Phase 1/2 EVEREST-2 Study During the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer A2 Biotherapeutics, Inc. ...
First-in-human trial uses the A2 Bio proprietary logic-gated Tmod™ technology platform for precision cell therapies providing selective killing of tumor cells while protecting normal cells AGOURA ...
Complex games like chess and Go have long been used to test AI models’ capabilities. But while IBM’s Deep Blue defeated reigning world chess champion Garry Kasparov in the 1990s by playing by the ...
A recent study has identified new lineages of human metapneumovirus (hMPV) — A2.2.1 and A2.2.2, highlighting its significant prevalence among children in Puducherry, India. Notable outbreaks occurred ...
The government last night awarded a $NZ1.15 million ($1.26m) High-Value Nutrition research grant to NZ research company AgResearch, which will work with the ...
Project 2025, a comprehensive transition plan organized by right-wing think tank The Heritage Foundation to guide the next GOP presidential administration, is the conservative movement’s most robust ...
SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC) (“Elastic”), the company behind Elasticsearch ®, today released a commissioned study conducted by Forrester Consulting on behalf of Elastic ®, The ...
Ask the publishers to restore access to 500,000+ books. An icon used to represent a menu that can be toggled by interacting with this icon. A line drawing of the Internet Archive headquarters building ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results